Quick Answer
STERIS plc reported Stockholders Equity of $6.60 billion for the year ending 2025.
- STERIS plc showed an increase of +4.8% in Stockholders Equity from 2024 to 2025.
- This data is from STERIS plc's annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $3.24 billion | Q3 2019: $3.23 billion | Q4 2019: $3.38 billion | Q2 2020: $3.47 billion | Q3 2020: $3.65 billion | Q4 2020: $3.87 billion | Q2 2021: $6.57 billion | Q3 2021: $6.54 billion | Q4 2021: $6.61 billion | Q2 2022: $6.41 billion | Q3 2022: $5.80 billion | Q4 2022: $6.04 billion | Q2 2023: $6.17 billion | Q3 2023: $6.18 billion | Q4 2023: $6.42 billion | Q2 2024: $6.35 billion | Q3 2024: $6.59 billion | Q4 2024: $6.42 billion | Q1 2025: $6.60 billion | Q2 2025: $6.96 billion | Q3 2025: $7.01 billion | Q4 2025: $7.15 billion.
- Over the full 8 years of available data (2018 to 2025), STERIS plc's Stockholders Equity has grown by 106.0%.
- Historical annual values: Fiscal year 2025: $6.60 billion | Fiscal year 2024: $6.30 billion | Fiscal year 2023: $6.08 billion | Fiscal year 2022: $6.53 billion | Fiscal year 2021: $3.88 billion | Fiscal year 2020: $3.41 billion | Fiscal year 2019: $3.18 billion | Fiscal year 2018: $3.21 billion.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: